Table 3 Psychotropic medication use over the trial duration in ASD+Participants
ASD+ | Study arm | Baseline (PBS = 47; TAU = 66) | 6 months (PBS = 42; TAU = 57) | 12 months (PBS = 42; TAU = 63) |
|---|---|---|---|---|
| Â | N (%) | |||
Any drug | PBS | 42 (89) | 37 (88) | 37 (88) |
TAU | 60 (91) | 51 (89) | 57 (90) | |
Antipsychotics | PBS | 32 (68) | 31 (74) | 27 (64) |
TAU | 42 (64) | 35 (61) | 39 (62) | |
Other psychotropic | PBS | 39 (83) | 30 (71) | 31 (74) |
TAU | 41 (62) | 41 (72) | 47 (75) | |